Target intelligence / Profile preview

DHCR24 divergent transcript (DHCR24-DT)

Target
DHCR24-DT
Molecular classification
Other (non-coding RNA gene)
01

Overview

DHCR24-DT (DHCR24 divergent transcript) is a non-coding RNA gene located in proximity to the DHCR24 protein-coding gene, which encodes 24-dehydrocholesterol reductase—a key enzyme in cholesterol biosynthesis. The divergent transcript is not a protein, therapeutic target, or classified receptor/enzyme, but may have regulatory genomic functions yet to be clarified. No information is available supporting its use, interaction with drugs, disease association, or role as a biomarker. The terms “ESSENCE, EGF Signal Sensing CAD’s Effect” are not referenced in standard gene, protein, or drug databases and appear to be incorrect or speculative aliases for DHCR24-DT. There is no evidence that DHCR24-DT functions in EGF signaling, CAD effect, or cholesterol biosynthesis as a protein or molecular target. If you are seeking information regarding the protein DHCR24 (24-dehydrocholesterol reductase), it is a well-established enzyme in cholesterol metabolism and associated with diseases such as desmosterolosis. However, DHCR24-DT (the divergent transcript) remains a poorly characterized non-coding RNA.

Other names
DHCR24 Divergent TranscriptDHCR24-DT
02

Mechanism of action

None established for drugs, as DHCR24-DT is not an established drug target.

03

Biological functions

Unknown. There is insufficient evidence for well-established biological functions; classified generally as a non-coding RNA gene, possible regulatory roles, but not established
04

Disease associations

Unknown. No clear association with specific diseases in current authoritative sources

Beyond the preview

Go deeper on DHCR24 divergent transcript (DHCR24-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DHCR24 divergent transcript (DHCR24-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call